DE60135647D1 - Zusammensetzungen zur normalisierung des zirkadianen rythmus - Google Patents

Zusammensetzungen zur normalisierung des zirkadianen rythmus

Info

Publication number
DE60135647D1
DE60135647D1 DE60135647T DE60135647T DE60135647D1 DE 60135647 D1 DE60135647 D1 DE 60135647D1 DE 60135647 T DE60135647 T DE 60135647T DE 60135647 T DE60135647 T DE 60135647T DE 60135647 D1 DE60135647 D1 DE 60135647D1
Authority
DE
Germany
Prior art keywords
action
circadian rhythm
composition
circadian
rythmus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60135647T
Other languages
English (en)
Inventor
Yoshinobu Kiso
Yoshiko Ono
Katsuya Nagai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE60135647D1 publication Critical patent/DE60135647D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Electrophonic Musical Instruments (AREA)
DE60135647T 2000-05-16 2001-05-15 Zusammensetzungen zur normalisierung des zirkadianen rythmus Expired - Lifetime DE60135647D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000143039 2000-05-16
PCT/JP2001/004027 WO2001087291A1 (fr) 2000-05-16 2001-05-15 Compositions permettant de regulariser le rythme circadien

Publications (1)

Publication Number Publication Date
DE60135647D1 true DE60135647D1 (de) 2008-10-16

Family

ID=18649909

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135647T Expired - Lifetime DE60135647D1 (de) 2000-05-16 2001-05-15 Zusammensetzungen zur normalisierung des zirkadianen rythmus

Country Status (11)

Country Link
US (1) US7001611B2 (de)
EP (1) EP1283038B1 (de)
AT (1) ATE406882T1 (de)
AU (1) AU780120B2 (de)
CA (1) CA2374958C (de)
DE (1) DE60135647D1 (de)
DK (1) DK1283038T3 (de)
ES (1) ES2312430T3 (de)
HK (1) HK1053269A1 (de)
PT (1) PT1283038E (de)
WO (1) WO2001087291A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7357947B2 (en) * 2001-09-10 2008-04-15 Biomet, Inc. Bone graft material incorporating demineralized bone matrix and lipids
WO2004084882A1 (en) 2003-03-27 2004-10-07 Suntory Limited Use of arachidonic acid for normalization of infradian rhythm
US20050071207A1 (en) * 2003-09-26 2005-03-31 E2Open Llc Visibility and synchronization in a multi tier supply chain model
US20070149509A1 (en) * 2003-12-18 2007-06-28 Luca Barella Use of vitamin e
JP4933097B2 (ja) * 2003-12-19 2012-05-16 株式会社メニコン 糖尿病および糖尿病合併症の治療・改善方法
US8086315B2 (en) 2004-02-12 2011-12-27 Asap Medical, Inc. Cardiac stimulation apparatus and method for the control of hypertension
AR056076A1 (es) * 2005-09-20 2007-09-19 Takeda Pharmaceutical Agente profilactico o terapeutico para el desorden de sueno
GB0523431D0 (en) * 2005-11-17 2005-12-28 Inst For Akvakulturforskning A Method
US8192773B2 (en) * 2006-12-22 2012-06-05 Kemin Industries, Inc. Carotenoid-based pigmenter
US20080171085A1 (en) * 2007-01-11 2008-07-17 Natrol, Inc. Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration
JP5356667B2 (ja) * 2007-09-28 2013-12-04 ユニチカ株式会社 体内時計正常化効果を有する組成物
CN103083643B (zh) * 2008-03-27 2015-01-07 雀巢产品技术援助有限公司 增加肽、肽模拟物和其他胃肠道转运蛋白底物吸收的方法
EP2123166A1 (de) * 2008-05-15 2009-11-25 Unilever N.V. Essbare Emulsionen mit Zitronensäureester
JP4409617B1 (ja) * 2008-12-04 2010-02-03 富士化学工業株式会社 カロテノイド色素の退色防止方法及びその容器体
WO2012078317A1 (en) * 2010-12-07 2012-06-14 Nestec S. A. Methods and compositions useful for promoting sleep in animals
RU2569743C2 (ru) * 2009-09-11 2015-11-27 Нестек С.А. Композиции и способы усиления когнитивной функции и связанных с ней функций у животных
CN104684583A (zh) * 2012-10-03 2015-06-03 富士胶片株式会社 睡眠改善剂、非快速眼动睡眠时间增加剂及镇静剂
US9008769B2 (en) 2012-12-21 2015-04-14 Backbeat Medical, Inc. Methods and systems for lowering blood pressure through reduction of ventricle filling
US9370662B2 (en) 2013-12-19 2016-06-21 Backbeat Medical, Inc. Methods and systems for controlling blood pressure by controlling atrial pressure
US10342982B2 (en) 2015-09-11 2019-07-09 Backbeat Medical, Inc. Methods and systems for treating cardiac malfunction
CN105193794B (zh) * 2015-11-12 2018-03-27 邵小春 一种睡眠喷剂及其制备方法
US10485658B2 (en) 2016-04-22 2019-11-26 Backbeat Medical, Inc. Methods and systems for controlling blood pressure
US10426400B2 (en) 2017-06-23 2019-10-01 International Business Machines Corporation Optimized individual sleep patterns
JP2022188309A (ja) * 2019-11-18 2022-12-21 Ｅｎｅｏｓ株式会社 睡眠の質の改善のための組成物
CN110882245A (zh) * 2019-12-16 2020-03-17 厦门市健康医疗大数据中心(厦门市医药研究所) 一种改善睡眠的组合物及其用途
RU2735833C1 (ru) * 2020-03-25 2020-11-09 Федеральное государственное бюджетное учреждение "Северо-Кавказский федеральный научно-клинический центр Федерального медико-биологического агентства" Способ коррекции десинхроноза суточных биоритмов человека, вызванного повышенными физическими и психоэмоциональными нагрузками
CN113144093B (zh) * 2021-05-23 2022-07-01 中国人民解放军海军第九七一医院 一种治疗昼夜节律紊乱的中药组合物与应用及其丸剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2619491B2 (ja) 1988-08-11 1997-06-11 サントリー株式会社 アスタキサンチン含有組成物
JPH05124958A (ja) 1991-09-19 1993-05-21 Yukio Date 過酸化脂質低下作用を有する組成物
JPH07300421A (ja) 1994-04-28 1995-11-14 Itano Reitou Kk 抗炎症剤
JPH09124470A (ja) 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
JPH10155459A (ja) 1996-11-27 1998-06-16 Suntory Ltd アスタキサンチン含有飲食物

Also Published As

Publication number Publication date
WO2001087291A1 (fr) 2001-11-22
EP1283038B1 (de) 2008-09-03
ATE406882T1 (de) 2008-09-15
EP1283038A1 (de) 2003-02-12
AU5674001A (en) 2001-11-26
US20030091614A1 (en) 2003-05-15
CA2374958A1 (en) 2001-11-22
US7001611B2 (en) 2006-02-21
DK1283038T3 (da) 2008-12-01
ES2312430T3 (es) 2009-03-01
AU780120B2 (en) 2005-03-03
HK1053269A1 (en) 2003-10-17
EP1283038A4 (de) 2003-06-25
PT1283038E (pt) 2008-10-23
CA2374958C (en) 2010-06-01

Similar Documents

Publication Publication Date Title
DE60135647D1 (de) Zusammensetzungen zur normalisierung des zirkadianen rythmus
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
ATE376828T1 (de) Verwendung von rotigotin zur behandlung und prävention des parkinson-plus-syndroms
ATE328599T1 (de) Antitumorale mittel
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
EP1767212A4 (de) Verwendung der pflanze der gattung ampelopsis und deren extrakte zur herstellung von arzneimitteln und functional food
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
DE60043318D1 (de) Synergistische kombination von pumafentrine und salmeterol
DE60204966D1 (de) Verwendung von cyclopamine zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
SI1778680T1 (sl) Spirociklični cikloheksanski derivati
HK1086548A1 (en) Deuterated catecholamine derivatives and medicaments comprising said compounds
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MXPA05013226A (es) Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas.
EP1415658A4 (de) Heilmittel
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2004010924A3 (en) Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof
SE0203817D0 (sv) New composition
ATE293983T1 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
ATE412411T1 (de) Pmcol zur behandlung von prostatakrebs
UA95094C2 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для лечения маниакального синдрома и биполярного расстройства

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SUNTORY HOLDINGS LTD., OSAKA, JP

8364 No opposition during term of opposition